Navigation Links
Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
Date:11/5/2009

hich may result in the discontinuation or delay of the research or development projects; the risk of technical obsolescence; the need for further regulatory approvals, which may not be obtained in a timely matter or at all; intellectual property risks, including without limitation, the risk that three patents for Topical Interferon Alpha-2b will expire in 2013 and no additional patent may be issued, that patent applications may not result in issued patents, that issued patents may be circumvented or struck down, and the risk of potential claims of infringement by the Company of third party intellectual property rights; marketing/manufacturing and partnership/strategic alliance risks; the effect of competition; uncertainty of the size and existence of a market opportunity for Helix's product; the risk that the Company's supplier of interferon alpha-2b may not continue to provide the Company with interferon alpha-2b or exercise its commercialization option, which would have a negative effect on the further development of the drug candidate and on the Company; and the risk of changes in business strategy or development plans. Certain of these risks and uncertainties, and others affecting the Company which could cause actual results to vary materially from current results or those anticipated in forward-looking statements and information, are more fully described in the Company's latest MD&A, Form20-F and other reports filed with the Canadian Securities Regulatory Authorities and the U.S. SEC from time to time at www.sedar.com and www.sec.gov/edgar.shtml, respectively. Forward-looking statements and information are based on the beliefs, assumptions, opinions and expectations of Helix's management at the time they are made, and Helix does not assume any obligation to update any forward-looking statement or information should those beliefs, assumptions, opinions or expectations change, except as required by law.


'/>"/>
SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Helix BioPharma Corp. Announces Fiscal 2009 Results
2. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
3. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
4. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
5. PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction
6. Lilly CEO Lechleiter Calls for Repair of the Engine of Biopharma Innovation
7. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
8. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
9. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
10. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
11. Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014 On Tuesday, July ... filed suit in the 116 th Judicial ... , against RegenLab USA, LLC ("Defendant") ... Business Relationships through false and misleading actions, ... Business Disparagement through libel, disparagement, defamation, misrepresentation, ...
(Date:7/23/2014)... -- The Centers for Medicare & Medicaid Services (CMS) ... Organization (QIN-QIO) contract to a partnership led by the ... 1, WVMI will launch Quality Insights Quality Innovation Network ... Pennsylvania , Delaware , ... will engage providers and the community in multiple, data-driven ...
(Date:7/23/2014)... July 23, 2014  RT Oncology Services Corporation today ... join its board of directors. Mr. Mundie is currently ... he works on strategic projects within the company and ... chief research and strategy officer. ... RainTree, said, "Craig is a visionary technology executive. His ...
Breaking Medicine Technology:Announcing a New Regional Approach to Medicare Quality Improvement 2Craig Mundie Joins RainTree Oncology Board of Directors 2Craig Mundie Joins RainTree Oncology Board of Directors 3
... --,Alfacell Corporation today announced that in vivo study ... of non-small cell lung cancer (NSCLC) were recently,published ... Based on the work of Intae Lee, Ph.D., ... Efficacy of the Cytotoxic,RNase, Ranpirnase, on A549 Human ...
... Problem of Antibiotic Resistance,Published in Nature Biotechnology, VANCOUVER, ... Inc.'s product candidate IDR-1 is the first,immune system ... to a paper published in the April 2007,issue ... the work of Inimex and its,co-founders Dr. Bob ...
Cached Medicine Technology:In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 2In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 3Inimex Product Candidate is First Immune Defense Regulator to Cure,Infections Without Causing Harmful Inflammation 2
(Date:7/23/2014)... “North America Cardiovascular Prosthetic Devices Market ... the North America Cardiovascular Prosthetic Devices market. The ... and volume (in units) and average price data ... Repairs and Septal Occluders. , The report also ... each of these market categories, and global corporate-level ...
(Date:7/23/2014)... By using brightly hued dyes, George Mason University ... proteins touch each other, possibly leading to new ... lung disease. , George Mason researchers unraveled the ... touch each other. "One protein interlocks with another ... and this sends a signal down the line ...
(Date:7/23/2014)... Splashtop , a leader ... it has joined the RSA Ready Technology Partner ... and RSA SecurID® multi-factor authentication solution from RSA, ... , Splashtop also announced that leading Japanese Insurance ... Enterprise, the industry’s only on-premise remote access solution. ...
(Date:7/23/2014)... On July 21, 2014, My Positive Perspective ... Tracey for an episode that spoke about the group Darkness ... Tracey to talk some about the formation of the group, ... it was started right here in Charleston, originally it was ... help survivors of sexual abuse. Their purpose has shifted to ...
(Date:7/23/2014)... Chicago, IL (PRWEB) July 23, 2014 ... equality successfully spreads across the country, understanding the ... building has never been more important. To help ... American Fertility Association (The AFA) is hosting a ... for lesbians in Chicago. , For lesbian couples, ...
Breaking Medicine News(10 mins):Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 2Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 3Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 4Health News:Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org 5Health News:Researchers unlock the protein puzzle 2Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 2Health News:Splashtop Joins RSA® Ready Technology Partner Program; Announces Adoption by Leading Japan Insurance Group Nissei Asset Management 3Health News:My Positive Perspective Airs Episode to Raise Attention to the Group Darkness to Light 2Health News:Gay Women’s Gathering ™ in Chicago: An Evening about Lesbian Pregnancy 2Health News:Gay Women’s Gathering ™ in Chicago: An Evening about Lesbian Pregnancy 3Health News:Gay Women’s Gathering ™ in Chicago: An Evening about Lesbian Pregnancy 4
... , , , ... Research Center (NIPTRC) announced today that Cherilyn Murer has been named Chair ... of NIPTRC is also a Northern Illinois University Trustee and concluded a ... June 30, 2009. , , "I am honored to ...
... University has produced the first batch of NY-ESO-1 recombinant ... for patients facing either ovarian cancer or melanoma. ... Ludwig Institute for Cancer Research and Cornell University. ... University Medical Center, while the ovarian cancer vaccine trial ...
... , , NEW YORK, Aug. 20 ... m ), an online global think tank featuring video interviews ... a new multimedia web series exploring the cutting edge of medical science ... , The online series answers a range of questions on ...
... premiums for employer-sponsored health insurance increased 119 percent between ... to an average $23,842 per family by 2020 if ... a new Commonwealth Fund report. The report, ... Up Middle Class Incomes, State Health Insurance Premium Trends ...
... , , WASHINGTON, Aug. 20 ... of a national "March for Healthcare" in Washington on September 13 ... option, Fattah announced today. , , The ... is calling on colleagues in Congress to endorse the proposal for ...
... invasive test focuses on nerve fibers, researchers say, , ... for endometriosis, the painful gynecologic condition that can impair ... studies show. , However, other experts said the accuracy ... of nerve fibers, needs to be replicated, which the ...
Cached Medicine News:Health News:Healthcare Expert Cherilyn Murer Named to Head Northern Illinois Proton Board 2Health News:Cornell makes cancer vaccine for clinical use 2Health News:Cornell makes cancer vaccine for clinical use 3Health News:Online Think Tank Big Think Launches New Multimedia Web Series Exploring Some of the Most Pressing Science and Medical Issues of our Time 2Health News:Online Think Tank Big Think Launches New Multimedia Web Series Exploring Some of the Most Pressing Science and Medical Issues of our Time 3Health News:Online Think Tank Big Think Launches New Multimedia Web Series Exploring Some of the Most Pressing Science and Medical Issues of our Time 4Health News:Employer-sponsored health insurance premiums projected to double by 2020 2Health News:Employer-sponsored health insurance premiums projected to double by 2020 3Health News:New Way Found to Diagnose Endometriosis 2Health News:New Way Found to Diagnose Endometriosis 3
1mm by 7mm horizontal punch. Flat serrated handle. Overall length 87mm....
... Central platform with integrated neck. Piston ... utilizing an internal spring to recoil ... Cutting Block fits into precision milled ... blades sized 6.25 - 9.0mm. Designed ...
Adjustable piston accommodates 7-9mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9mm trephine blades and 18mm diameter Teflon block. Designed for accurate donor...
... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...
Medicine Products: